Browse treatments

…n tumor and immune cells. The ultimate goal is to reliably test immunotherapy interventions and reduce eventual clinical failures by means of…

…f Phe and AKK maximally inhibited 5-HIAA synthesis and improved immunotherapy efficacy.Conclusions Our investigations reveal that alterations…

…ut challenges persist in achieving durable responses. Combining immunotherapy with radiotherapy has emerged as a promising strategy. Stereota…

…rapy that is extending and improving countless lives worldwide. Checkpoint inhibitor immunotherapy has become a standard of care treatment for over 20 distinct ty…

…ontinua, hemiparesis and cognitive decline. Early initiation of immunomodulatory therapy is crucial to slow disease progression. However, early formal d…

…t al, via target trial emulation, reported better outcomes with immunotherapy. However, limitations such as lack of key clinical variables, h…

…ted inhibitory tumor immune microenvironment, thereby enhancing immunotherapy effectiveness. Mechanistically, RC48-ADC reactivates the tumor …

…ations on the immune landscape of NSCLC, their implications for immunotherapy resistance, and potential strategies to overcome these barriers…

…CSCC, durable disease control frequently occurred after limited immunotherapy exposure, and clinical responders often did well without routin…

… Therefore, we evaluated the combination of this inhibitor with immunotherapy as a promising new approach for the treatment of tumors in the …

…nd highlight their strong potential as targets for T-cell-based immunotherapy.Conclusions Our work is the first to demonstrate that non-canon…

…cause of cancer morbidity and mortality worldwide, and although immunotherapy has revolutionized cancer treatment, its efficacy in gastric ca…